Search research articles
Contact Us
Filters
Showing results (151-160 of 1,050) with videos related to
Page
of 105
Sort By:
Annals of the Rheumatic Diseases
|
April 15, 2010
Risk prediction for severe osteoarthritis
Georg Schett, Jochen Zwerina, Roland Axmann, et al.
European Journal of Immunology
|
January 27, 2012
IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1
Inessa Schwab, Markus Biburger, Gerhard Krönke, et al.
Plos One
|
August 25, 2017
Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants
Lena Tschiderer, Johann Willeit, Georg Schett, et al.
Annals of the Rheumatic Diseases
|
April 19, 2019
Comment on: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco <i>et al</i>
Johannes Knitza, Lorenzo Cavagna, Georg Schett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 8, 2022
FAPI PET Opens a New Window to Understanding Immune-Mediated Inflammatory Diseases
Torsten Kuwert, Christian Schmidkonz, Olaf Prante, et al.
Arthritis Research & Therapy
|
December 6, 2011
T cells as key players for bone destruction in gouty arthritis?
Ulrike Harre, Anja Derer, Christine Schorn, et al.
Nature Medicine
|
January 10, 2012
Autoimmunity's next top models
Hartmut Wekerle, Alexander Flügel, Lars Fugger, et al.
Seminars in Arthritis and Rheumatism
|
July 22, 2008
Churg-Strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patients
Jochen Zwerina, Gerhard Eger, Matthias Englbrecht, et al.
Annals of the Rheumatic Diseases
|
October 13, 2010
A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis
Stephanie Finzel, Matthias Englbrecht, Klaus Engelke, et al.
Therapeutic Advances in Musculoskeletal Disease
|
August 8, 2012
Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases
Georg Schett, Victor S Sloan, Randall M Stevens, et al.
Page
of 105
Search research articles
Search
Showing results (151-160 of 1,050) with videos related to
Sort By:
Page
of 105
Annals of the Rheumatic Diseases
|
April 15, 2010
Risk prediction for severe osteoarthritis
Georg Schett, Jochen Zwerina, Roland Axmann, et al.
European Journal of Immunology
|
January 27, 2012
IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1
Inessa Schwab, Markus Biburger, Gerhard Krönke, et al.
Plos One
|
August 25, 2017
Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants
Lena Tschiderer, Johann Willeit, Georg Schett, et al.
Annals of the Rheumatic Diseases
|
April 19, 2019
Comment on: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco <i>et al</i>
Johannes Knitza, Lorenzo Cavagna, Georg Schett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 8, 2022
FAPI PET Opens a New Window to Understanding Immune-Mediated Inflammatory Diseases
Torsten Kuwert, Christian Schmidkonz, Olaf Prante, et al.
Arthritis Research & Therapy
|
December 6, 2011
T cells as key players for bone destruction in gouty arthritis?
Ulrike Harre, Anja Derer, Christine Schorn, et al.
Nature Medicine
|
January 10, 2012
Autoimmunity's next top models
Hartmut Wekerle, Alexander Flügel, Lars Fugger, et al.
Seminars in Arthritis and Rheumatism
|
July 22, 2008
Churg-Strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patients
Jochen Zwerina, Gerhard Eger, Matthias Englbrecht, et al.
Annals of the Rheumatic Diseases
|
October 13, 2010
A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis
Stephanie Finzel, Matthias Englbrecht, Klaus Engelke, et al.
Therapeutic Advances in Musculoskeletal Disease
|
August 8, 2012
Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases
Georg Schett, Victor S Sloan, Randall M Stevens, et al.
Page
of 105